Clinical Trials Logo

Type 1 Diabetes clinical trials

View clinical trials related to Type 1 Diabetes.

Filter by:

NCT ID: NCT05799781 Recruiting - Type 1 Diabetes Clinical Trials

Two Way Crossover Closed Loop MPC vs Control IQ

Start date: March 13, 2023
Phase: N/A
Study type: Interventional

An artificial pancreas (AP) is a control system for automatic insulin delivery. The investigators have implemented a missed meal bolus detection algorithm for use within an AP control system. If a meal is detected that was not reported by the user, the system shall calculate the amount of meal insulin that will be dosed and deliver that insulin. The investigators will test how well the new algorithm manages glucose compared to the participant's usual care including the tslim X2 pump with Control IQ enabled. This type of algorithm may improve glucose control for high risk patient populations.

NCT ID: NCT05795309 Recruiting - Type 1 Diabetes Clinical Trials

Automated Insulin Delivery in Type 1 Diabetes Complicated by Gastroparesis

AIDgastro
Start date: August 16, 2023
Phase: N/A
Study type: Interventional

This is a staggered randomised controlled trial that aims to assess the impact of an automated insulin delivery (AID) system on glucose, gastrointestinal and patient-reported outcomes.

NCT ID: NCT05794581 Recruiting - Type 1 Diabetes Clinical Trials

A Study to Assess the Effects of CT-868 Treatment on Glucose Homeostasis in Participants With Type 1 Diabetes

Start date: March 21, 2023
Phase: Phase 1
Study type: Interventional

This study will be conducted primarily to evaluate the effects of CT-868 on glucose homeostasis in participants with Type 1 Diabetes Mellitus.

NCT ID: NCT05793645 Recruiting - Type 1 Diabetes Clinical Trials

Clinical Investigation to Assess the Feasibility of a New Diabetes Management Program

ODIN
Start date: May 15, 2023
Phase: N/A
Study type: Interventional

The goal of this interventional study is to assess the adherence to a personalized care plan in patients (12-15 years) with Type 1 diabetes

NCT ID: NCT05791201 Recruiting - Type 1 Diabetes Clinical Trials

A Safety, Tolerability, and Efficacy Study of VX-264 in Participants With Type 1 Diabetes

Start date: May 16, 2023
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of the study is to evaluate the safety, tolerability, and efficacy of VX-264 in participants with type 1 diabetes (T1D).

NCT ID: NCT05790785 Recruiting - Type 1 Diabetes Clinical Trials

Vascular Complications in Children From T1D Diagnosis

Start date: December 1, 2023
Phase:
Study type: Observational

Cardiovascular disease is a complication of type 1 diabetes (T1D), a life-long disease, usually diagnosed in childhood. The goal of this project is to determine the timing and factors leading to vascular damage in children from T1D diagnosis.

NCT ID: NCT05788341 Recruiting - Type 1 Diabetes Clinical Trials

The Israeli Study for Islet Autoantibodies Screening in Families of Type-1 Diabetes Patients

Start date: May 30, 2023
Phase:
Study type: Observational

We aim at establishing a research program that will offer screening for the presence of Islet Autoantibodies (IA) in relatives of people with Type 1 Diabetes (T1D). Relatives of people with diabetes, children, and adults from our clinic and all over Israel will be offered to participate in the study. The presence of IA will be evaluated using the Detection by Agglutination-PCR (ADAP) technology developed by Enable Biosciences, which is 1,000-10,000 times more analytically sensitive than currently used methods.. When positive in the screening, multiple antibodies will be confirmed by a second sample analyzed by the ADAP technology and by a radio binding assay (RBA). People positive for one or more antibodies (stage 1 or 2 T1D) will be referred to attend an educational program at our center. This program will include diabetes education emphasizing DKA prevention as well as stress assessment for the families involved and stress alleviating interventions. After the educational visit, people at risk of developing diabetes will be referred to further follow-up and evaluation under routine medical care at our center.

NCT ID: NCT05768191 Recruiting - Type 1 Diabetes Clinical Trials

Comparative Efficacy of a Two Daily Mixed Insulin Injection Versus a Basal-bolus Scheme With Human Insulin

Start date: June 15, 2023
Phase: Phase 4
Study type: Interventional
Read more »
NCT ID: NCT05767450 Recruiting - Type 1 Diabetes Clinical Trials

Intervention on New Onset-T1D Children

Start date: December 16, 2022
Phase: N/A
Study type: Interventional

A pilot proof of concept clinical trial will be performed to demonstrate the restoration of gut barrier integrity by administration of beneficial anti-inflammatory gut microbial strains (Lactobacilli-enriched Vivomixx® probiotic) to new onset Type 1 Diabetes Children.

NCT ID: NCT05749029 Completed - Type 2 Diabetes Clinical Trials

An Online, Compassion Intervention for Adults With Type 1 and Type 2 Diabetes Mellitus (T1DM; T2DM).

Start date: May 1, 2023
Phase: N/A
Study type: Interventional

The goal of this research study is to evaluate a programme that is based on Compassionate Mind Training (CMT) over four-weeks. The programme intends to share information and strategies to reduce diabetes distress, self-criticism, and shame, and improve physical health in people who have Type 1 and Type 2 Diabetes Mellitus.